Emirates Drug Establishment (EDE), the federal medicines regulator
Is Liraglutide legal in United Arab Emirates?
ApprovedMarketed in the UAE as Saxenda for obesity care according to Novo Nordisk's UAE professional portal; EDE register entry not verified
The regulator has approved it as a medicine.
Novo Nordisk's UAE portal for healthcare professionals lists Saxenda (liraglutide) as an obesity-care product, which indicates it is marketed here as a prescription medicine. I could not open the EDE register or find an approval date, exact indication wording, or a Victoza entry, so treat these details as unconfirmed. Under the earlier 2019 medicines law, promotion of prescription-only medicines was limited to healthcare professionals, and the 2024 decree-law requires EDE approval for any advertising.
Last verified 2026-09-29 · how we verify
Liraglutide elsewhere
Sources (3)
- 01Saxenda by Novo Nordisk | Obesity Care for Professionals (Novo Nordisk UAE portal for healthcare professionals)Novo Nordisk UAE · 2026 · accessed 2026-09-29
- 02CMS Expert Guide to advertising of medicines and medical devices: United Arab EmiratesCMS · 2024-05-08 · accessed 2026-09-29
- 03Pharmaceutical licensing and drug registration in the UAE (Federal Decree-Law 38 of 2024)Kayrouz and Associates · 2026-03-18 · accessed 2026-09-29